Skip to main content
. 2007 Oct 10;27(41):10969–10981. doi: 10.1523/JNEUROSCI.2961-07.2007

Figure 3.

Figure 3.

Pharmacology of afterpotential modulation in granule cells. A, Left, Plot of the afterpotential response integral in CCh (2 μm) and after bath application of the M1 mAChR antagonist pirenzepine (10 μm) and CCh. Pirenzepine abolishes the ADP response evoked by 50 pA depolarizing steps in CCh and restores the AHP normally present in granule cells under control conditions. Example traces shown above plot. Right, Bath application of the M2 mAChR antagonist AF-DX 116 (1 μm; 50 pA step) does not block the ADP in granule cells. B, Bath application of the M1 mAChR agonist MCN-A-343 (100 μm; 50 pA step) mimicked the effect of CCh and converted the normal AHP response into an ADP. Control and MCN-A-343 traces are shown overlapped on right. Action potentials truncated in the step responses in A and B are shown. All example responses in A are from approximately −55 mV; responses in B are from −50 mV. C, Summary of the effects of atropine and M1 and M2 receptor agents on the afterpotential integral in granule cells. *p < 0.01; **p < 0.0001.